<?xml version="1.0" encoding="UTF-8"?>
<p>Parents completed the Canadian Acute Respiratory Illness and Flu Scale (CARIFS)
 <sup>
  <xref rid="R22" ref-type="bibr">22</xref>
 </sup> questionnaire at scheduled visits (day 1–15), and responses were used to measure secondary efficacy endpoints including time to alleviation of signs and symptoms (TTASS) of influenza [defined as when a score of 0 (no problem) or 1 (minor problem) was reported for cough and nasal symptoms on the CARIFS questionnaire, return to normal health and activity, and return to afebrile state (tympanic temperature ≤37.2°C), remaining for at least 21.5 hours]. Subgroup analyses of TTASS based on virus subtype were also performed.
</p>
